Human Myeloperoxidase Antigen Native
| Catalog number: | B2016975 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Human Myeloperoxidase Antigen Native |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Audrain MA, Baranger TA, Moguilevski N, Martin SJ, Devys A, Lockwood CM, Muller JY, Esnault VL. Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies Clin Exp Immunol. 1997 Jan;107(1):127-34.
- Nonokawa M, Suzuki K, Hayashi H, Nishibata Y, Masuda S, Nakazawa D, Tanaka S, Tomaru U, Ishizu A. Native myeloperoxidase is required to make the experimental vasculitis model Arthritis Res Ther. 2019 Dec 21;21(1):296.
- Falk RJ, Becker M, Terrell R, Jennette JC. Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase Clin Exp Immunol. 1992 Aug;89(2):274-8.
- Ehrenstein MR, Leaker B, Isenberg D, Cambridge G. Production of human monoclonal antibodies to myeloperoxidase Immunology. 1992 Dec;77(4):617-20.
- Chistiakov DA, Orekhov AN, Bobryshev YV. ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease Lab Invest. 2016 Jul;96(7):708-18.
- Yun S, Ryu H, Lee EK. Immunomagnetic separation of human myeloperoxidase using an antibody-mimicking peptide identified by phage display J Biotechnol. 2017 Sep 10;257:118-121.
- Yamanishi Y, Ito-Ihara T, Nagao T, Uno K, Kobayashi S, Muso E, Shane PY, Firestein GS, Hashimoto H, Okazaki T, Suzuki K. Clinical features of patients with anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen Mod Rheumatol. 2013 Sep;23(5):963-71.
- Chen X, Duong MN, Nicholls SJ, Bursill C. Myeloperoxidase modification of high-density lipoprotein suppresses human endothelial cell proliferation and migration via inhibition of ERK1/2 and Akt activation Atherosclerosis. 2018 Jun;273:75-83.
- Boomsma MM, Stegeman CA, Oost-Kort WW, Kallenberg CG, Moguilevsky N, Limburg PC, Tervaert JW. Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis J Immunol Methods. 2001 Aug 1;254(1-2):47-58.
